Skip to content
Not actual size.
The only once daily, combination

SPRAY FOAM

for the treatment of plaque psoriasis in patients 12 years and older.1
THE #1 PRESCRIBED BRANDED TOPICAL FOR PLAQUE PSORIASIS2

See the data on long-term treatment with Enstilar® Spray Foam

IN THE PRESCRIBING INFORMATION:
Proven efficacy for up to 52 weeks with twice-weekly dosing1

Consider Enstilar® Spray Foam

for the treatment of plaque psoriasis

The only combination spray foam with 2 active ingredients—a corticosteroid and a vitamin D analog1

Proven efficacy combined with rapid results1

Once-daily regimen1
The first and only topical plaque psoriasis treatment with long-term, 52-week efficacy data1,3
Not an actual pay card.

Eligible commercially insured patients may pay as little as $20*

for each Enstilar® Spray Foam prescription

*Certain restrictions apply. This card may reduce out-of-pocket expenses. Must be 12 years of age or older to be eligible, and a legal guardian over 18 years of age must redeem the card for patients aged 12 to 17. You are not eligible if you are enrolled or you participate in any state or federally funded health care program (eg, Medicare, Medicaid, etc). Click here for Full Terms and Conditions and Eligibility Requirements or call 1-877-678-7494 between 8:30 AM and 8:30 PM (Eastern), Monday through Friday.

Downloadable resources

The Enstilar® Spray Foam
Patient Instructions for Use
The Enstilar® Spray Foam Patient Profile

Watch this video to learn how to apply Enstilar® Spray Foam

References: 1. Enstilar® [prescribing information]. LEO Pharma Inc. 2. IQVIA NPA MAT January 2021 [February 2020 – January 2021]. 3. Lebwohl M, Kircik L, Lacour J-P, et al. Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial). J Am Acad Dermatol. 2020;S0190-9622(20)32625-32625.